Latest Earli News & Updates
See the latest news and media coverage for Earli. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of tumor-selective genetic therapies and diagnostics
earli.com- Headquarters
- Redwood City, United States
- Founded year
- 2018
- Company type
- Private company
- Number of employees
- 30–50
Last updated
Latest news about Earli
Company announcements
-
Earli CEO urges Trump to prioritize biotech innovations
He highlights U.S. funding challenges, China's rise, and proposes a national biotech fund and regulatory reforms. Biotech faces structural risks threatening leadership.
-
Earli announces $44m funding to reprogram cancer cells
The total funding raised by Earli is now $104m. Investors include a16z Bio + Health, Khosla Ventures, and new prominent backers. The company aims to start clinical trials soon.
-
Earli presents new cancer treatment at DLD Munich
The post discusses Earli's innovative approach to cancer treatment showcased at the DLD Munich event on January 21, 2025.
-
Earli celebrates the holiday season
Earli combines cutting-edge biotechnology with traditional holiday spirit in their seasonal greeting.
Media coverage
-
Exclusive: Cancer biotech Earli seeks $60M Series B
Earli, a Bay Area biotech developing novel cancer drugs, is seeking to raise a $60 million Series B round, CEO Cyriac Roeding tells Axios Pro...
-
Earli Profile | The Scientist
Earli is a Stanford spinout developing a new approach to cancer treatment and tackling the “holy grail” in oncology of destroying cancer cells while safeguarding...
-
The Heartbreaking Loss of a Child to Cancer Brought These 3 Founders Together. Now Their Startup Has Raised $60 Million to Fight and Treat the Disease With Cutting-Edge Tech. | Entrepreneur
What happens when a Silicon Valley entrepreneur, a synthetic biology expert, and a world-renowned cancer researcher team up? They create Earli—a startup rewriting the rules...
-
Using synthetic biomarkers for early cancer detection | TechTarget
Accenture invests in Earli Inc., a biotechnology company that is using synthetic targeting platforms for early cancer detection.
Track Earli and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Earli competitors & trending companies
Browse news for competitors to Earli and other trending companies.
Humane Genomics
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove